218 related articles for article (PubMed ID: 29909344)
1. Involvement of the TGFβ1- ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy.
Zhang Y; Wang B; Guo F; Li Z; Qin G
Biomed Pharmacother; 2018 Sep; 105():766-772. PubMed ID: 29909344
[TBL] [Abstract][Full Text] [Related]
2. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
3. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
6. PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Krepinsky JC
J Am Soc Nephrol; 2009 Mar; 20(3):554-66. PubMed ID: 19211711
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
8. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin.
Ma X; Ding J; Min H; Wen Y; Gao Q
Int Immunopharmacol; 2013 Nov; 17(3):752-8. PubMed ID: 24055008
[TBL] [Abstract][Full Text] [Related]
9. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
Deepa B; Venkatraman Anuradha C
Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
11. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
[TBL] [Abstract][Full Text] [Related]
13. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway.
Chen YJ; Kong L; Tang ZZ; Zhang YM; Liu Y; Wang TY; Liu YW
Biomed Pharmacother; 2019 Mar; 111():1166-1175. PubMed ID: 30841430
[TBL] [Abstract][Full Text] [Related]
14. The potential therapeutic effects of Trifolium alexandrinum extract, hesperetin and quercetin against diabetic nephropathy via attenuation of oxidative stress, inflammation, GSK-3β and apoptosis in male rats.
Abdou HM; Abd Elkader HAE
Chem Biol Interact; 2022 Jan; 352():109781. PubMed ID: 34922902
[TBL] [Abstract][Full Text] [Related]
15. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
Wang T; Chen SS; Chen R; Yu DM; Yu P
Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.
Rai U; Kosuru R; Prakash S; Tiwari V; Singh S
Eur J Pharmacol; 2019 Dec; 865():172763. PubMed ID: 31682792
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
20. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]